Trial Profile
A Randomized, Single-dose, Open, Crossover Clinical Trial to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; Ezetimibe; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Alvogen
- 12 Apr 2016 New trial record